New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 8, 2017 – The FDA approved Dr. Reddy’s Minolira (minocycline) extended-release tablets to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older.
Download PDF
Return to publications
